LOINC
Version 2.73

LP16202-1MethylphenidateActive

Descriptions

LP16202-1   Methylphenidate
Methylphenidate (brand name Ritalin) is a central nervous system (CNS) stimulant used in the treatment of attention deficit hyperactivity disorder (ADHD). It is also used to treat depression, narcolepsy, brain injury, cancer, pain, cognitive disorders and to treat patients with human immunodeficiency virus infection. Methylphenidate can be admistered orally, intravenously or intranasally. This medication can be habit forming and has potential for abuse. Intranasal abuse can mimic the effects cocaine in both onset and type as it provides a rapid release of synaptic dopamine that causes an instant feeling of euphoria. Side effects can include insomnia, stomach ache, headache, and anorexia. [PMID:15014637] Source: Regenstrief LOINC

LP16202-1   Methylphenidate
A central nervous system stimulant used most commonly in the treatment of attention-deficit disorders in children and for narcolepsy. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. Source: National Library of Medicine, MeSH 2006

Basic Part Properties

Name
Methylphenidate
Type
Component
Created On
2000-05-04
Construct for LOINC Short Name
Me-phenidate

LOINC FHIR® API Example - CodeSystem Request Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP16202-1

Language Variants Get Info

zh-CNChinese (China)
哌甲酯
nl-NLDutch (Netherlands)
methylfenidaat
et-EEEstonian (Estonia)
Metüülfenidaat
fr-BEFrench (Belgium)
Méthylphénidate
fr-CAFrench (Canada)
Méthylphénidate
it-ITItalian (Italy)
Metilfenidato
ru-RURussian (Russian Federation)
Метилфенидат
es-ESSpanish (Spain)
Metilfenidato
Synonyms: Ritalin
tr-TRTurkish (Turkey)
Metilfenidat